REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$11.99
Tradestie Score
51
Market Cap
$328.62M
Analyst Upside
+62.6%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$41.93
|
$1.17B | - | 60 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$21.06
|
$1.15B | 4.9 | 50 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$12.94
|
$1.14B | - | 69 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$13.63
|
$1.14B | - | 47 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$31.95
|
$1.13B | - | 40 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$3.35
|
$1.12B | - | 60 | Compare |
|
NKTR
Nektar Therapeutics
|
$38.65
|
$1.12B | - | 61 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$258.92
|
$1.12B | - | 61 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$7.54
|
$1.09B | - | 53 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$10.67
|
$1.05B | 74.2 | 61 | Compare |
More REPL Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry